Edition:
United Kingdom

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

66.00CHF
15 Dec 2017
Change (% chg)

CHF-0.40 (-0.60%)
Prev Close
CHF66.40
Open
CHF66.25
Day's High
CHF66.30
Day's Low
CHF65.70
Volume
85,986
Avg. Vol
107,491
52-wk High
CHF68.25
52-wk Low
CHF52.05

Latest Key Developments (Source: Significant Developments)

BB Biotech Q3 net profit down at CHF 365 million
Friday, 20 Oct 2017 

Oct 20 (Reuters) - BB BIOTECH AG ::PRODUCT APPROVALS AND SOLID COMPANY RESULTS LEAD THE BIOTECH SECTOR HIGHER.Q3 ‍NET PROFIT AMOUNTED TO CHF 365 MN VERSUS PROFIT OF CHF 392 MN REPORTED IN Q3 LAST YEAR​.  Full Article

BB Biotech swings to prelim Q3 profit of CHF 392.1 mln
Tuesday, 11 Oct 2016 

BB Biotech AG : BB Biotech AG with profit in the third quarter 2016 . Based on preliminary unaudited consolidated results, BB Biotech closed Q3 of 2016 with a profit of 392.1 million Swiss francs ($401.41 million)(575.4 million francs loss in corresponding period of previous year) .For nine months period ended September 30, 2016 BB Biotech reports a loss of 777.8 million Swiss francs (141.4 million francs profit in corresponding period of previous year).  Full Article

BB Biotech reports 5.1 pct passive stake in Esperion Therapeutics
Tuesday, 27 Sep 2016 

Esperion Therapeutics Inc :BB Biotech AG reports 5.1 pct passive stake in Esperion Therapeutics as of September 22, 2016 - SEC filing.  Full Article

BB Biotech Q2 net profit of CHF 36 mln
Friday, 22 Jul 2016 

BB Biotech AG : Expects a return to growth from its portfolio holdings in coming quarters and for FY 2016 as a whole . Q2 net profit of 36 million Swiss francs ($36.59 million) .Net result for first half was a negative 1170 million Swiss francs due to loss reported for Q1.  Full Article

BB Biotech swings to H1 net loss of CHF 1.17 bln
Monday, 11 Jul 2016 

BB Biotech AG :Based on preliminary unaudited consolidated results, BB Biotech AG closed first half year of 2016 with a loss of 1.17 billion Swiss francs ($1.19 billion)(717 million Swiss francs profit in corresponding period of previous year)..  Full Article

BB Biotech proposes dividend of 14.50 Swiss francs per share
Friday, 19 Feb 2016 

BB Biotech AG:Further significant increase in dividend of 25 pct to 14.50 Swiss francs per share, five-for-one share split proposed​ ‍.In its outlook for 2016, BB Biotech expects more announcements of regulatory approvals as well as strong pipeline newsflow from its portfolio companies​.  Full Article

BB Biotech AG proposed FY 2015 dividend
Friday, 22 Jan 2016 

BB Biotech AG:Raises dividend to 14.50 francs per share for 2015 and proposes share split of 1:5.  Full Article

Bumper crop of new drugs fails to lift big pharma R&D returns

LONDON, Dec 14 It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.